SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a report that the company is preparing a potential takeover offer for eBay, fueling community speculation about a massive strategic shift and a possible short squeeze. While bulls are energized by the prospect of a high-stakes merger and potential gamma ramp, some investors remain skeptical about the financing feasibility and long-term viability of the deal.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a significant surge in momentum as speculative traders position for a potential short squeeze ahead of its upcoming earnings report. With a high percentage of the float sold short and limited share availability, the community is actively rallying behind the stock, focusing on the potential for forced short covering and long-term growth in the AI sector.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending following a Wall Street Journal report that GameStop is building a stake and weighing a potential acquisition of the e-commerce giant. While investors are debating the ambitious math behind a merger between the two companies, the community is actively discussing the feasibility of such a deal, potential deal structures, and whether this represents a long-term strategic pivot or an engineered short-term pump.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting intense investor attention following positive pharmacokinetic data and emerging coverage for its flagship fibromyalgia treatment, Tonmya. Community discourse remains deeply divided between long-term bulls highlighting potential market expansion and vocal bears concerned about historical dilution, recurring reverse split proposals, and ongoing cash burn.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is trending as the community highlights its ultra-low circulating supply and zero future dilution as key catalysts for potential price appreciation. Investors are actively discussing the possibility of a significant breakout should volume return to the asset, drawing parallels to its historical highs and comparing its tokenomics to larger cryptocurrencies.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2025 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is currently trending as a high-conviction buyout candidate, with investors actively discussing potential interest from major players like Netflix, Amazon, or Sony following the company's recent strategic spin-off. The community is heavily focused on the studio's strong IP library and the blockbuster box office potential of the Michael Jackson biopic as key catalysts that could drive a premium acquisition.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as community members focus on long-term accumulation and project utility, highlighting recent educational initiatives on their platform alongside bullish sentiment regarding future product developments. The community is actively rallying around the 'Wagmi' mindset, emphasizing project longevity and resilience as key drivers for potential recovery.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is drawing significant investor attention due to the upcoming launch of a new under $3 value menu and $4 breakfast deals, a strategic pivot aimed at reclaiming market share among budget-conscious consumers. While the community is actively debating the effectiveness of these pricing initiatives against rising operational costs and intense competition, the stock's defensive appeal continues to attract interest as a potential safe-haven asset in a volatile market.

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

Advanced Biomed Inc

Advanced Biomed is trending due to speculative momentum surrounding its low-float profile and recent clinical developments in precision medicine, with the community actively debating whether the stock is primed for a parabolic short squeeze or is simply a pump-and-dump scheme. Market participants are closely watching for potential breakout patterns as retail traders highlight low share supply as a catalyst for outsized price volatility.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing extreme volatility and heavy retail attention as traders speculate on a potential short squeeze, despite significant skepticism regarding the stock's fundamentals and long-term sustainability. Community discourse is polarized, with many bulls looking for continued upward momentum and short-squeeze mechanics, while others caution against a possible rug pull as they monitor price action and short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Context Therapeutics (CNTX) to Release Quarterly Earnings on Wednesday

Context Therapeutics (NASDAQ:CNTX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

Context Therapeutics (NASDAQ:CNTX)  Shares Down 7%   - Time to Sell?

Context Therapeutics (NASDAQ:CNTX) Shares Down 7% - Here's What Happened...

Neogen Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary

Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced the appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary. Ms. Stacey is an accomplished chief legal and compliance officer and board secretary with extensive...

Context Therapeutics (NASDAQ:CNTX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded Context Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...

Context Therapeutics Inc. (NASDAQ:CNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Context Therapeutics Inc. (NASDAQ:CNTX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine research firms that are currently covering the stock, MarketBeat...

Q1 EPS Forecast for Context Therapeutics Lowered by Analyst

Context Therapeutics Inc. (NASDAQ:CNTX - Free Report) - Equities research analysts at Lifesci Capital reduced their Q1 2026 earnings per share estimates for Context Therapeutics in a report issued on...

HC Wainwright Brokers Reduce Earnings Estimates for CNTX

Context Therapeutics Inc. (NASDAQ:CNTX - Free Report) - Research analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for Context Therapeutics in a research report...

Context Therapeutics' (CNTX) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $9.00 price target on shares of Context Therapeutics in a research report on Tuesday...

Context Therapeutics (NASDAQ:CNTX) Receives Buy Rating from Guggenheim

Guggenheim restated a "buy" rating and issued a $5.00 target price on shares of Context Therapeutics in a research note on Tuesday...

Context Therapeutics (NASDAQ:CNTX) Price Target Raised to $7.00

Piper Sandler lifted their price objective on shares of Context Therapeutics from $4.00 to $7.00 and gave the stock an "overweight" rating in a research note on Tuesday...

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The firm's robust clinical program for candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. Its ONA-XR is a novel, first-in-class small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women?s cancers. The company was founded by Martin Lehr and Felix Kim in April 2015 and is headquartered in Philadelphia, PA.

CNTX
Context Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest CNTX News

CNTXContext Therapeutics Inc